Author:
Alhaddad Hasan,Ospina Oscar E.,Khaled Mariam Lotfy,Ren Yuan,Forsyth Peter A.,Pina Yolanda,Macaulay Robert,Law Vincent,Tsai Kenneth Y.,Cress W. Douglas,Fridley Brooke,Smalley Inna
Reference63 articles.
1. Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions;I C Glitza;Pigment Cell Melanoma Res,2020
2. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases;M L Khaled;Cancers (Basel),2023
3. Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy;K S Smalley;Int J Cancer,2016
4. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD);S D Ferguson;J Neurooncol,2019
5. Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance;I Smalley;Clin Cancer Res,2020